Regen BioPharma Inc (RGBP)

[the reaper]

Great News. Another Step FWD !!Dr. Patel Brings 7 Mil in Grants !!

Main Focus for use of dCellVax is Breast Cancer
An App is Pending/Awaiting Approval From FDA for Clearance of Usage for/in Human Trials !!!!!!

GROUND FLOOR OPPORTUNITY Dr. Patel was instrumaental is Interexeron's Buy Out and Move to NYSE !!!

SAN DIEGO, CA--(Marketwired - Oct 15, 2014) - Regen BioPharma Inc. (OTCBB: RGBP) announced today the appointment of Dr. Amit Patel to the company's Scientific Advisory Board (SAB). Dr. Patel is Director of Clinical Regenerative Medicine and Tissue Engineering at the University of Utah and has been involved in over 17 FDA trials in the area of cellular therapy. Dr. Patel currently holds more than $7 million in research grants for basic and clinical research in the area of regenerative medicine. (Don Ho former Patient of Dr. Patel-Congestive Heart Failure-Stem Cell treatment)


http://finance.yahoo.com/news/cell-therapy-expert-dr-amit-140000551.html